WESTBURY, N.Y., June 5, 2012 /PRNewswire/ -- We are pleased to announce that David Jaworski has joined Lachman Consultants as a Director in its Compliance Practice. David comes to Lachman from FDA where he most recently served as Acting Branch Chief, Domestic Compliance Branch, Division of Domestic Drug Quality (DDDQ) in the Office of Manufacturing and Product Quality (OMPQ)/Office of Compliance/CDER. In this position, David was responsible for the management, review, approval and resolution of recommended enforcement actions based on violation of GMP requirements and standards for product quality and data integrity. This included Warning Letters, Untitled Letters, Consent Decrees of Permanent Injunction, and Product Seizures. He was a member of the Drug Shortage Investigation team and helped develop some of the novel approaches to resolving drug shortages. David was actively involved in the scientific and regulatory evaluation and development of policy and requirements for parenteral and PET drugs. David previously served FDA as Team Leader for the Domestic Compliance Manufacturing Branch (DCMB), Acting Branch Chief for the International Compliance Branch and Case Officer, DCMB. Prior to the FDA, David worked in the pharmaceutical industry for over thirty years and held management positions at various companies including IVAX, Sandoz, Bristol Myers, Abbott and William H. Rorer, Inc. He also has experience with bacterial fermentation and CHO cell bioreactor operations. Academically, David was awarded an M.B.A. degree, Operations & Management, Syracuse University and a B.S. degree, Microbiology, Pennsylvania State University. David is a member of the American Society for Microbiology as well as the Parenteral Drug Association.
For more than 30 years, Lachman Consultants has been the leader in providing cost-effective consultation and remediation services to the worldwide pharmaceutical, biotechnology, biologic, medical device, diagnostic and dietary supplement industries. With its strong and extensive cadre of consultant specialists and an unparalleled management team, its Compliance, Science & Technology, and Regulatory Practices provide the most expert counsel and array of services available. Lachman Consultants is proud of its tradition of supporting industry efforts to develop and ensure safe, effective and high-quality medical products. It remains committed to helping the industry anticipate and address its challenges through the development and implementation of practical, sustainable and cost-effective solutions based on the integration of scientific principles, evolving regulatory expectations, and technology.
Contact: Michele Sinoway, [email protected], +1-516-222-6222, or fax, +1-516-683-1887
SOURCE Lachman Consultant Services, Inc.